EHS
EHS

No substantial benefit from transplantation reported for a high-risk leukemia subtype



Checking for minimal residual disease early in treatment can help some young high-risk leukemia patients avoid bone marrow transplantation without compromising their long-term survival A St. Jude Children’s Research Hospital investigator led the international retrospective analysis that appears today in the Journal of Clinical Oncology.

Source link

EHS
Back to top button